---
figid: PMC6775438__medi-98-e17303-g001
figtitle: Metabolic pathway of tyrosine
organisms:
- Homo sapiens
- Meleagris gallopavo
organisms_ner:
- NA
pmcid: PMC6775438
filename: medi-98-e17303-g001.jpg
figlink: /pmc/articles/PMC6775438/figure/F1/
number: F1
caption: Metabolic pathway of tyrosine. Fumarylacetoacetate hydrolase is the deficient
  enzyme in tyrosinemia type 1. NTBC inhibits the upstream enzyme 4-hydroxyphenylpyruvate
  dioxygenase preventing the formation of the toxic metabolites fumarylacetoacetate
  and succinylacetoacetate. NTBC = nitisinone.
papertitle: Evolution of tyrosinemia type 1 disease in patients treated with nitisinone
  in Spain.
reftext: María Luz Couce, et al. Medicine (Baltimore). 2019 Sep;98(39):e17303.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7959743
figid_alias: PMC6775438__F1
figtype: Figure
redirect_from: /figures/PMC6775438__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6775438__medi-98-e17303-g001.html
  '@type': Dataset
  description: Metabolic pathway of tyrosine. Fumarylacetoacetate hydrolase is the
    deficient enzyme in tyrosinemia type 1. NTBC inhibits the upstream enzyme 4-hydroxyphenylpyruvate
    dioxygenase preventing the formation of the toxic metabolites fumarylacetoacetate
    and succinylacetoacetate. NTBC = nitisinone.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Phenylalanine
  - Tyrosine
  - Iyrosine
  - 4-OH-phenylpyruvate 4-OH-phenyllactate
  - 4-OH-phenylpyruvate
  - Homogentisic acid
  - Maleylacetoacetate
  - Fumarylacetoacetate
  - Fumarate
  - acetoacetate
---
